(3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine hydrochloride
(3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine hydrochloride ??? ???
?? ??:
477600-68-3
???:
(3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine hydrochloride
???(??):
Tofacitinib Impurity 2 DiHCl;1-Benzyl-N,4-diMethylpipe...;1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE;CIS-1-benzyl-N,4-dimethylpiperidin-3-amine hydrochloride;-rel-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride;(3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine hydrochloride;(3S,4S)-1-BENZYL-N,4-DIMENTHYLPIPERIDIN-3-AMINEHYDROCHLORIDE;cis-1-Benzyl-N-Methyl-4-Methylpiperidin-3-aMine dihydrochloride;cis-1-Benzyl-4-methyl-3-(methylamino)piperidine dihydrochloride;(3R,4R)-rel-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride
CBNumber:
CB21564712
???:
C14H22N2.2(HCl)
??? ??:
0
MOL ??:
477600-68-3.mol
(3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine hydrochloride ??
?? ??
Store at room temperature
??
White to off-white Solid
InChI
InChI=1S/C14H22N2/c1-12-8-9-16(11-14(12)15-2)10-13-6-4-3-5-7-13/h3-7,12,14-15H,8-11H2,1-2H3
InChIKey
NVKDDQBZODSEIN-UHFFFAOYSA-N
SMILES
C1N(CC2=CC=CC=C2)CC(NC)C(C)C1
??
?? ? ?? ??
?? ? ???? ?? (GHS)
????(GHS):
?? ?:
Warning
??·?? ??:
??
??·?? ??
?? ??
??
?? ?
?? ??
P- ??
H302 ??? ???
?? ?? ?? - ??
?? 4
??
P264, P270, P301+P312, P330, P501
H315 ??? ??? ???
????? ?? ?????
?? 2
??
P264, P280, P302+P352, P321,P332+P313, P362
H319 ?? ?? ??? ???
?? ? ?? ?? ??? ??
?? 2A
??
P264, P280, P305+P351+P338,P337+P313P
H335 ?? ???? ??? ? ??
?? ???? ?? - 1? ??;???? ??
?? 3
??
??????:
P261 ??·?·??·???·??·...·????? ??? ????.
P280 ????/???/???/?????? ?????.
P301+P312 ??? ???? ??? ????(??)? ??? ????.
P302+P352 ??? ??? ??? ?? ????.
P305+P351+P338 ?? ??? ? ?? ?? ???? ????. ???? ?????? ?????. ?? ????.
(3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine hydrochloride C??? ??, ??, ??
??
(3R,4R)-rel-N,4-Dimethyl-1-(phenylmethyl)-3-piperidinamine Dihydrochloride is used as a reagent in the preparation of cis-3-Methylamino-4-methylpiperidines and also in synthesis of piperidine derivatives as immunosuppressant for the treatment of diseases associated with pathologic JAK3 activation.
(3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine hydrochloride ?? ?? ? ???
???
?? ??
(3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine hydrochloride ?? ??
???( 79)?? ??
China 72
United States 7
Global 79
(3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine hydrochloride ?? ??:
?? ??
Tofacitinib citrate
CYANOACETIC ACID-OSU
N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
3-Piperidinamine,4-methyl-1-(phenylmethyl)-,(3R,4R)-rel-
Tofacitinib
4-METHYL-3-METHYLAMINOPYRIDINE
N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
Methyl cis-3-(Boc-amino)cyclobutanecarboxylate
4-Amino-2,6-dichloropyrimidine
3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI)
Malonyl chloride
(3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride
(3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine
N-Hydroxysuccinimide
Tofacitinib Impurity 2
